Human T‐lymphotropic virus type I (HTLV‐I)–associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is an immune‐mediated inflammatory disorder of the central …

The efficacy of long-term, high dose interferon-α (IFN-α) therapy was studied in seven
patients with HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP). IFN-α …

This review examines information on clinical, pathological and immunological events in the
slowly progressive neurologic disorder associated with the human T lymphotropic virus type …

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is an inflammatory neurological disease caused by HTLV-I infection …

Human T-lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a slowly progressive, inflammatory disease of the central nervous …

This review focuses on current approaches to understanding the immunopathogenesis of
human T cell lymphotropic virus (HTLV) type I–associated myelopathy/tropical spastic …

Human T‐lymphotropic virus type I (HTLV‐I)‐associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a neurological disease that results from an interaction of retroviral …

TSP/HAM, a chronic spastic paraparesis or paraplegia with sphincter disturbances and
minimal sensory loss, is characterized pathologically by a meningo-myelitis of the lower …

Human T-cell lymphotropic virus type I (HTLV-I) infection is associated with a variety of
human diseases. In particular, there are two major diseases caused by HTLV-I infection …

Human T-cell leukemia virus type I (HTLV-I)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) represents one of the most devastating diseases associated with …